市場調査レポート

商品コード

1449296

動物用API（医薬品有効成分）製造の世界市場：シェア、規模、動向、産業分析レポート - サービスタイプ別、合成タイプ別、動物タイプ別、治療カテゴリ別、地域別、セグメント予測、2024年～2032年

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type ; By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032

出版日: 2024年02月24日 | 発行: Polaris Market Research

| ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,250 666,230円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 822,990円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 979,750円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の動物用API（医薬品有効成分）製造の市場規模は2032年までに146億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

動物用APIは動物用医薬品の必須成分です。これらの成分は望ましい治療効果を生み出す役割を担っており、商業的使用が承認される前に厳しい試験や調査が行われます。動物ヘルスケアソリューションの需要が増加し続ける中、高品質の動物用API市場も急成長しています。市場は、動物用医薬品の研究開発、アウトソーシングへの投資の増加、施設の拡張、動物の健康に対する支出など、多くの要因によって成長すると予想されます。

動物用API市場は、APIの製造をアウトソーシングすることによる運用面および費用対効果のメリットによって牽引されています。動物用医薬品企業は、業務を最適化しコストを削減する方法を積極的に模索しています。動物用API製造を専門メーカーに委託することで、製薬会社は研究開発、マーケティング、流通など、自社の中核的な強みに集中することができます。この動向は、動物の健康と福祉の重要性に対する意識の高まりに後押しされ、動物用API市場の大幅な拡大につながった。

動物用API市場は、越境感染や人獣共通感染症の流行の高まりにより、著しい成長を遂げています。これらの病気は動物と人間の集団の両方に重大なリスクをもたらし、国境を越えて急速に広がる可能性があるため、公衆衛生、世界貿易、動物福祉に脅威を与えています。動物用APIの使用は、これらの疾病の蔓延を抑制・予防する上で極めて重要となっています。動物用医薬品は、罹患動物の治療、効果的な治療戦略の開発、罹患動物の回復を助ける症状の重症度の軽減において極めて重要な役割を果たしています。動物用API製造セクターは非常に多様で、さまざまな動物種の多様な健康ニーズに対応しています。大手多国籍製薬会社から中堅企業まで、幅広い企業で構成されています。

動物用API製造市場レポートハイライト

市場は、主に自社でAPI製造施設を設立した数多くの大手動物用医薬品メーカーの存在により、自社製造部門が支配的です。この戦略的な動きにより、サプライチェーンが途切れないようにし、製品の品質を厳格に管理しています。

動物用API製造市場は、評価期間中、生物学的API分野で大幅な成長が見込まれます。この成長は、動物ヘルスケア向けの高度な生物製剤やワクチンのニーズが高まっていることに起因しています。

2023年、動物用API製造の世界市場は、抗感染症分野が最大の貢献者でした。これは、動物の細菌、真菌、ウイルス感染症を治療するための抗生物質やその他の抗微生物剤の需要が大きいためです。

2023年の世界市場は北米地域が支配的であったが、これは主に米国やカナダなどの国々で動物ヘルスケア産業が確立されているためです。これらの産業の存在が動物用APIの高い需要をもたらし、北米を動物用APIの最大市場にしています。

主な調査結果
イントロダクション
- 動物用API製造市場評価：地域別（2019年～2032年）
動物用API製造市場 - 北米
- サービスタイプ別
- 動物タイプ別
- 合成タイプ別
- 治療カテゴリー別
- 米国
- カナダ
動物用API製造市場 - 欧州
- サービスタイプ別
- 動物タイプ別
- 合成タイプ別
- 治療カテゴリー別
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
動物用API製造市場 - アジア太平洋
- サービスタイプ別
- 動物タイプ別
- 合成タイプ別
- 治療カテゴリー別
- 中国
- インド
- 日本
- マレーシア
- インドネシア
- 韓国
動物用API製造市場 - 中東・アフリカ
- サービスタイプ別
- 動物タイプ別
- 合成タイプ別
- 治療カテゴリー別
- サウジアラビア
- 南アフリカ
- イスラエル
- UAE
動物用API製造市場 - ラテンアメリカ
- サービスタイプ別
- 動物タイプ別
- 合成タイプ別
- 治療カテゴリー別
- メキシコ
- ブラジル
- アルゼンチン

第10章競合情勢

拡張と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第11章企業プロファイル

Alivira Animal Health Ltd.
Chempro Pharma Pvt. Ltd
Elanco
Excel Industries Ltd.
MENADIONA
Ofichem Group
Qilu Animal Health Products Co., Ltd.
Siflon Drugs
SUANFARMA
Vetpharma
Zoetis

図表

List of Tables

Table 1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, by Region, 2019-2032 (USD Billion)
Table 2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, by Region, 2019-2032 (USD Billion)
Table 3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, by Region, 2019-2032 (USD Billion)
Table 4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, by Region, 2019-2032 (USD Billion)
Table 5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 6 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 7 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 8 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 9 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 10 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 11 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 12 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 13 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 14 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 15 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 16 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 17 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 18 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 19 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 20 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 21 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 22 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 23 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 24 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 25 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 26 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 27 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 28 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 29 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 30 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 31 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 32 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 33 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 34 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 35 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 36 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 37 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 38 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 39 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 40 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 41 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 42 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 43 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 44 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 45 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 46 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 47 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 48 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 49 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 50 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 51 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 52 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 53 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 54 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 55 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 56 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 57 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 58 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 59 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 60 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 61 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 62 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 63 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 64 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 65 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 66 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 67 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 68 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 69 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 70 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 71 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 72 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 73 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 74 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 75 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 76 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 77 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 78 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 79 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 80 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 81 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 82 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 83 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 84 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 85 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 86 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 87 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 88 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 89 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 90 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 91 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 92 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 93 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 94 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 95 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 96 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 97 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 98 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 99 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 100 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 101 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 102 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 103 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 104 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 105 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 106 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 107 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 108 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 109 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
Table 110 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
Table 111 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
Table 112 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
Table 113 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Animal Type
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Service Type
Figure 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2021 & 2030 (USD Billion)
Figure 8. Market by Animal Type
Figure 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2021 & 2030 (USD Billion)
Figure 10. Market by Synthesis Type
Figure 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2021 & 2030 (USD Billion)
Figure 12. Market by Therapeutic Category
Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2021 & 2030 (USD Billion)

Product Code: PM4540

The global Veterinary Active Pharmaceutical Ingredients Manufacturing market size is expected to reach USD 14.63 Billion by 2032, according to a new study by Polaris Market Research. The report "Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type (In House, Contract Outsourcing); By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary active pharmaceutical ingredients (APIs) are essential components of animal medicines. These ingredients are responsible for producing the desired therapeutic effects and undergo rigorous testing and research before they are approved for commercial use. As the demand for animal healthcare solutions continues to increase, the market for high-quality veterinary APIs is also growing rapidly. The market is anticipated to grow owing to numerous factors such as research & development of veterinary products, increasing investment in outsourcing, facility expansion, and expenditure on animal health.

The veterinary active pharmaceutical ingredient (API) market has been driven by the operational and cost-effectiveness benefits of outsourcing the manufacturing of APIs. Animal health companies are actively seeking ways to optimize their operations and reduce costs. By outsourcing the production of veterinary APIs to specialized manufacturers, pharmaceutical companies can focus on their core strengths, including research, development, marketing, and distribution. This trend has led to a significant expansion in the veterinary API market, driven by a growing awareness of the importance of animal health and welfare.

The market for veterinary active pharmaceutical ingredients (APIs) is witnessing significant growth owing to the rising prevalence of transboundary and zoonotic diseases. These diseases pose a significant risk to both animal and human populations and can spread rapidly across borders, posing a threat to public health, global trade, and animal welfare. The use of veterinary APIs has become crucial in controlling and preventing the spread of these diseases. They play a pivotal role in treating diseased animals, developing effective treatment strategies, and reducing the severity of symptoms, which aids in the recovery of affected animals. The veterinary API manufacturing sector is highly diverse and caters to the varied health needs of different animal species. It comprises a broad spectrum of companies ranging from large multinational pharmaceutical corporations to mid-sized enterprises.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

The market is dominated by the in-house segment, mainly due to the presence of numerous leading animal health companies that have set up their own API manufacturing facilities. This strategic move has helped them ensure an uninterrupted supply chain and maintain strict control over the quality of their products.

The veterinary API manufacturing market is projected to witness substantial growth in the biological API segment in the assessment period. This growth can be attributed to the rising need for advanced biologics and vaccines for animal healthcare.

In 2023, the global market for manufacturing veterinary active pharmaceutical ingredients (API) had the anti-infective segment as the largest contributor. This was due to the significant demand for antibiotics and other anti-microbial agents to treat bacterial, fungal, and viral infections in animals.

The global market in 2023 was dominated by the North American region, primarily due to the well-established animal healthcare industries in countries such as the United States and Canada. The presence of these industries has resulted in a high demand for veterinary APIs, making North America the largest market for veterinary APIs.

The global key market players include Alivira Animal Health Ltd., Chempro Pharma Pvt. Ltd., Elanco, Excel Industries Ltd., MENADIONA, Ofichem Group, Qilu Animal Health Products Co., Ltd., Siflon Drugs, SUANFARMA, Vetpharma, Zoetis, and among others.

Polaris Market Research has segmented the Veterinary Active Pharmaceutical Ingredients Manufacturing market report based on service type, synthesis type, animal type, therapeutic category, and region:

Veterinary Active Pharmaceutical Ingredients Manufacturing, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)

In House
Contract Outsourcing
Contract Development
Preclinical Development
Clinical Development
Contract Manufacturing

Veterinary Active Pharmaceutical Ingredients Manufacturing, Synthesis Type Outlook (Revenue - USD Billion, 2019 - 2032)

Biological API
Chemical-based API
HPAPI

Veterinary Active Pharmaceutical Ingredients Manufacturing, Animal Type Outlook (Revenue - USD Billion, 2019 - 2032)

Production Animals
Companion Animals

Veterinary Active Pharmaceutical Ingredients Manufacturing, Therapeutic Category Outlook (Revenue - USD Billion, 2019 - 2032)

Antiparasitic
Anti-infectives
NSAIDs
Others

Veterinary Active Pharmaceutical Ingredients Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of APAC
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of MEA

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing - Industry Snapshot
4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing prevalence of transboundary and zoonotic diseases fuels veterinary active pharmaceutical ingredients manufacturing market growth
  - 4.2.1.2. The cost-effectiveness and operational advantages of outsourcing API manufacturing drives market growth
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. The high cost of veterinary diagnostic and treatment hampers veterinary active pharmaceutical ingredients manufacturing market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
5.3. In-house
- 5.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In-house, by Region, 2019-2032 (USD Billion)
5.4. Contract Outsourcing
- 5.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2019-2032 (USD Billion)
- 5.4.2. Contract Development
  - 5.4.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2019-2032 (USD Billion)
  - 5.4.2.2 Preclinical Development
  - 5.4.2.21. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2019-2032 (USD Billion)
  - 5.4.2.3 Clinical Development
  - 5.4.2.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2019-2032 (USD Billion)
- 5.4.3. Contract Manufacturing
  - 5.4.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2019-2032 (USD Billion)

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
6.3. Biological API
- 6.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2019-2032 (USD Billion)
6.4. Chemical-based API
- 6.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2019-2032 (USD Billion)
6.5. HPAPI
- 6.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2019-2032 (USD Billion)

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
7.3. Antiparasitic
- 7.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitic, by Region, 2019-2032 (USD Billion)
7.4. Anti-infectives
- 7.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2019-2032 (USD Billion)
7.5. NSAIDs
- 7.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2019-2032 (USD Billion)
7.6. Others
- 7.6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
8.3. Production Animals
- 8.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2019-2032 (USD Billion)
8.4. Companion Animals
- 8.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2019-2032 (USD Billion)

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

9.1. Key findings
9.2. Introduction
- 9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - North America
- 9.3.1. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
- 9.3.2. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
- 9.3.3. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
- 9.3.4. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - U.S.
  - 9.3.5.1. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.3.5.2. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.3.5.3. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.3.5.4. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Canada
  - 9.3.6.1. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.3.6.2. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.3.6.3. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.3.6.4. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
9.4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Europe
- 9.4.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
- 9.4.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
- 9.4.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
- 9.4.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UK
  - 9.4.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.4.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.4.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.4.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.4.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - France
  - 9.4.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.4.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.4.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.4.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.4.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Germany
  - 9.4.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.4.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.4.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.4.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.4.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Italy
  - 9.4.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.4.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.4.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.4.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.4.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Spain
  - 9.4.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.4.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.4.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.4.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.4.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Netherlands
  - 9.4.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.4.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.4.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.4.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.4.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Russia
  - 9.4.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.4.11.2. Russia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.4.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.4.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
9.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Asia Pacific
- 9.5.1. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.5.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - China
  - 9.5.5.1. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.5.5.2. China.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.5.5.3. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.5.5.4. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.5.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - India
  - 9.5.6.1. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.5.6.2. India.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.5.6.3. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.5.6.4. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.5.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Japan
  - 9.5.7.1. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.5.7.2. Japan.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.5.7.3. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.5.7.4. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.5.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Malaysia
  - 9.5.8.1. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.5.8.2. Malaysia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.5.8.3. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.5.8.4. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.5.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Indonesia
  - 9.5.9.1. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.5.9.2. Indonesia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.5.9.3. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.5.9.4. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.5.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Korea
  - 9.5.10.1. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.5.10.2. South Korea.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.5.10.3. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.5.10.4. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
9.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.6.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.6.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Africa
  - 9.6.6.1. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.6.6.2. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.6.6.3. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.6.6.4. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.6.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Israel
  - 9.6.7.1. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.6.7.2. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.6.7.3. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.6.7.4. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.6.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UAE
  - 9.6.8.1. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.6.8.2. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.6.8.3. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.6.8.4. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
9.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Latin America
- 9.7.1. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.7.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Mexico
  - 9.7.5.1. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.7.5.2. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.7.5.3. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.7.5.4. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.7.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Brazil
  - 9.7.6.1. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.7.6.2. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.7.6.3. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.7.6.4. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
- 9.7.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Argentina
  - 9.7.7.1. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  - 9.7.7.2. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  - 9.7.7.3. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  - 9.7.7.4. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Alivira Animal Health Ltd.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Chempro Pharma Pvt. Ltd
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Elanco
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Excel Industries Ltd.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. MENADIONA
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Ofichem Group
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Qilu Animal Health Products Co., Ltd.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Siflon Drugs
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. SUANFARMA
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Vetpharma
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Zoetis
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development

動物用API（医薬品有効成分）製造の世界市場：シェア、規模、動向、産業分析レポート - サービスタイプ別、合成タイプ別、動物タイプ別、治療カテゴリ別、地域別、セグメント予測、2024年～2032年

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type ; By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032

動物用API製造市場レポートハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の動物用API製造市場の洞察

第5章世界の動物用API製造市場：サービスタイプ別

第6章世界の動物用API製造市場：合成タイプ別

第7章世界の動物用API製造市場：治療カテゴリー別

第8章世界の動物用API製造市場：動物タイプ別

第9章世界の動物用API製造市場：地域別

第10章競合情勢

第11章企業プロファイル

List of Tables

List of Figures

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

Veterinary Active Pharmaceutical Ingredients Manufacturing, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)

Veterinary Active Pharmaceutical Ingredients Manufacturing, Synthesis Type Outlook (Revenue - USD Billion, 2019 - 2032)

Veterinary Active Pharmaceutical Ingredients Manufacturing, Animal Type Outlook (Revenue - USD Billion, 2019 - 2032)

Veterinary Active Pharmaceutical Ingredients Manufacturing, Therapeutic Category Outlook (Revenue - USD Billion, 2019 - 2032)

Veterinary Active Pharmaceutical Ingredients Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

10. Competitive Landscape

11. Company Profiles

動物用API（医薬品有効成分）製造の世界市場：シェア、規模、動向、産業分析レポート - サービスタイプ別、合成タイプ別、動物タイプ別、治療カテゴリ別、地域別、セグメント予測、2024年～2032年

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type ; By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032

動物用API製造市場レポートハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の動物用API製造市場の洞察

第5章 世界の動物用API製造市場：サービスタイプ別

第6章 世界の動物用API製造市場：合成タイプ別

第7章 世界の動物用API製造市場：治療カテゴリー別

第8章 世界の動物用API製造市場：動物タイプ別

第9章 世界の動物用API製造市場：地域別

第10章 競合情勢

第11章 企業プロファイル

List of Tables

List of Figures

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

Veterinary Active Pharmaceutical Ingredients Manufacturing, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)

Veterinary Active Pharmaceutical Ingredients Manufacturing, Synthesis Type Outlook (Revenue - USD Billion, 2019 - 2032)

Veterinary Active Pharmaceutical Ingredients Manufacturing, Animal Type Outlook (Revenue - USD Billion, 2019 - 2032)

Veterinary Active Pharmaceutical Ingredients Manufacturing, Therapeutic Category Outlook (Revenue - USD Billion, 2019 - 2032)

Veterinary Active Pharmaceutical Ingredients Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

10. Competitive Landscape

11. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の動物用API製造市場の洞察

第5章世界の動物用API製造市場：サービスタイプ別

第6章世界の動物用API製造市場：合成タイプ別

第7章世界の動物用API製造市場：治療カテゴリー別

第8章世界の動物用API製造市場：動物タイプ別

第9章世界の動物用API製造市場：地域別

第10章競合情勢

第11章企業プロファイル